Based on DS3 scores, patients are grouped into mild (
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Aim: Patients with Fabry disease frequently die due to cardiovascular causes.
📊
Key Findings & Data:In this study,we evaluated epicardial fat thickness and parameters of diastolic dysfunction among Fabry patients as a possible indicator ofdisease severity.Materials and Methods: We enrolled 14 patients with Fabry disease who receive enzyme replacement therapy.
💡
Conclusion & Impact:Based on DS3 scores, patients are grouped into mild (
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Aim: Patients with Fabry disease frequently die due to cardiovascular causes. There are numerous findings of cardiovascularinvolvement in patients with Fabry disease. Epicardial fat thickness is a surrogate for various cardiovascular diseases. In this study,we evaluated epicardial fat thickness and parameters of diastolic dysfunction among Fabry patients as a possible indicator ofdisease severity.Materials and Methods: We enrolled 14 patients with Fabry disease who receive enzyme replacement therapy. Detailedechocardiographic examination was performed including diastolic functions and measurement of epicardial fat thickness. Diseaseseverity was assessed using DS3 scoring system. Based on DS3 scores, patients are grouped into mild (
🔖
Cite This Article
SUCU, M., ALTUNBAŞ, G., OZKAYA, M., SAYİNER, Z. A. (2022). The association of epicardial fat thickness and disease severity among Fabry patients. Annals of Medical Research, Cilt: 26 - Sayı: 9, 1947–1950. https://ajindex.com/articles/446733
Germain DP. Fabry disease. Orphanet J Rare Dis 2010;5:30 2. Baig S, Edward NC, Kotecha D, Liu B, Nordin S, Kozor R, et al. Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice. Europace 2017 doi: 10.1093/europace/eux261. 3. Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol2015;11:363-71 4. Rozenfeld P, Feriozzi S. Contribution of inflammatory pathways to Fabry disease pathogenesis. Mol Genet Metab. 2017;122:19-27 5. Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am SocEchocardiogr 2009;22:1311-9 6. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 2016;29:277-314 7. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 2015;28:1-39. 8. Giannini EH, Mehta AB, Hilz MJ, Beck M, Bichet DG, Brady RO, et al. A validated disease severity scoring system for Fabry disease. Mol Genet Metab 2010;99:283-90 9. Levey AS, Greene T, Kusek JW, Beck GL; MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000 Sep; 11:155A 10. Iacobellis G, Assael F, Ribaudo MC, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003;11:304-10. 11. Iacobellis G, Willens HJ, Barbaro G, et al. Threshold values for high-risk echocardiographic epicardial fat thickness. Obesity (Silver Spring) 2008;16:887-92. 12. Constricte A, Petramala L, Scoccia G, et al. Epicardial fat thickness in patients with autosomal dominant polycystic kidney disease. Cardiorenal Med 2018;8:199-207. 13. Iacobeliis G, Barbarini G, Letizia C, et al. Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects. Obesity (Silver Spring) 2014;22:332-6. 14. Gürdal A, Keskin K, Orken DN, et al. Evaluation of epicardial fat thickness in young patients with embolic stroke of undetermined source. Neurologist 2018;23